MedPath

Efficacy check of skin care product

Not Applicable
Registration Number
CTRI/2023/12/060574
Lead Sponsor
SATIYA NUTRACEUTICALS PRIVATE LIMITED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Skin is healthy on the studied anatomic unit

2)Having mild to moderate acne

3)Having mixed oily or oily skin on the face.

4)Having visible pores

Exclusion Criteria

1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form.

2)Taking part in another study liable to interfere with this study.

3)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area

4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)

5)Having a progressive asthma (either under treatment or last fit in the last 2 years)

6)Being epileptic

7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)

8)Having cutaneous hypersensitivity

9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex

10) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)

11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

12)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit

13)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

14)Having applied hair oil during the entire duration of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in acne reduction in pore size, reduction in skin sebum content & improvement in skin brightnessTimepoint: Baseline, Day 3, Day 7, Day 14
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath